Abbott Laboratories (ABT) Cash from Operations Growth (3y) (2012 - 2026)
Abbott Laboratories (ABT) Cash from Operations Growth (3y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.14 Bn | 173.84 Bn | 6.27 Bn | 4.78% |
| 2 | Stryker | 128.35 Bn | 125.47 Bn | 3.81 Bn | 9.30% |
| 3 | Medtronic | 107.95 Bn | 98.73 Bn | 6.41 Bn | 1.51% |
| 4 | Boston Scientific | 68.16 Bn | 66.71 Bn | 3.61 Bn | 22.35% |
| 5 | Edwards Lifesciences | 47.67 Bn | 44.00 Bn | 1.29 Bn | -48.14% |
| 6 | GE HealthCare Technologies | 28.45 Bn | 26.17 Bn | 1.98 Bn | -14.75% |
| 7 | Dexcom | 28.45 Bn | 27.33 Bn | 750.30 Mn | 50.11% |
| 8 | Smith & Nephew | 26.83 Bn | 26.25 Bn | - | - |
| 9 | Koninklijke Philips | 25.36 Bn | 22.23 Bn | 2.07 Bn | 0.50% |
| 10 | Steris | 21.42 Bn | 20.98 Bn | 697.10 Mn | 15.83% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.78% |
| Dec 31, 2025 | 12.54% |
| Sep 30, 2025 | 0.08% |
| Jun 30, 2025 | -5.30% |
| Mar 31, 2025 | -11.80% |
| Dec 31, 2024 | -2.21% |
| Sep 30, 2024 | 0.05% |
| Jun 30, 2024 | -2.70% |
| Mar 31, 2024 | -27.02% |
| Dec 31, 2023 | -7.17% |
| Sep 30, 2023 | -3.15% |
| Jun 30, 2023 | -3.10% |
| Mar 31, 2023 | 16.93% |
| Dec 31, 2022 | -1.26% |
| Sep 30, 2022 | 12.59% |
| Jun 30, 2022 | 31.49% |
| Mar 31, 2022 | 42.61% |
| Dec 31, 2021 | 20.22% |
| Sep 30, 2021 | 7.36% |
| Jun 30, 2021 | 19.60% |